Phase II study of Tarceva [erlotinib] plus Temodar [temozolomide] during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Erlotinib; Temozolomide
- Indications Brain cancer; Glioblastoma; Sarcoma
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.